Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,262 | 36 | 98.6% |
| Education | $17.84 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $481.07 | 18 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $399.60 | 10 | $0 (2021) |
| Allergan Inc. | $173.21 | 3 | $0 (2017) |
| Aerie Pharmaceuticals, Inc. | $111.73 | 1 | $0 (2019) |
| OCULUS, Inc. | $44.01 | 1 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $38.46 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $18.98 | 1 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $12.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.62 | 1 | Bausch & Lomb Americas Inc. ($20.62) |
| 2023 | $17.84 | 1 | Bausch & Lomb Americas Inc. ($17.84) |
| 2021 | $29.99 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($29.99) |
| 2020 | $36.34 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($36.34) |
| 2019 | $496.80 | 13 | Shire North American Group Inc ($230.15) |
| 2018 | $310.51 | 8 | Bausch & Lomb, a division of Bausch Health US, LLC ($241.34) |
| 2017 | $367.89 | 10 | Shire North American Group Inc ($181.75) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Ophthalmology | ||||||
| 07/31/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 08/23/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, LOTEPREDNOL ETABONATE | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Ophthalmology | ||||||
| 06/04/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, LOTEPREDNOL ETABONATE | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Ophthalmology | ||||||
| 10/20/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BEPREVE, ALREX | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/08/2019 | OCULUS, Inc. | OCULUS Keratograph 5M (Device) | Food and Beverage | Cash or cash equivalent | $44.01 | General |
| Category: eye diagnostic | ||||||
| 10/03/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE (Device), ULTRA, BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $73.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/19/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/18/2019 | Aerie Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $111.73 | General |
| 06/24/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: OPTHALMICS | ||||||
| 06/10/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: OPTHALMICS | ||||||
| 05/13/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: OPTHALMICS | ||||||
| 04/11/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: OPTHALMICS | ||||||
| 03/08/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: OPTHALMICS | ||||||
| 02/26/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $88.90 | General |
| Category: OPTHALMICS | ||||||
| 02/15/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: OPTHALMICS | ||||||
| 01/11/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: OPTHALMICS | ||||||
| 12/24/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/21/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: OPTHALMICS | ||||||
| 10/29/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: OPTHALMICS | ||||||
| 08/29/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $88.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/28/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: OPTHALMICS | ||||||
| 06/26/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA, ZYLET | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 316 | 434 | $68,835 | $33,898 |
| 2022 | 6 | 350 | 463 | $71,995 | $34,681 |
| 2021 | 6 | 295 | 373 | $57,405 | $29,187 |
| 2020 | 5 | 293 | 375 | $53,919 | $24,660 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 210 | $32,150 | $16,916 | 52.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 77 | 79 | $18,385 | $9,790 | 53.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $4,445 | $2,763 | 62.2% |
| 92250 | Photography of the retina | Office | 2023 | 59 | 62 | $6,595 | $1,646 | 25.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 30 | 32 | $3,060 | $1,557 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 33 | $4,200 | $1,226 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 188 | $29,560 | $15,399 | 52.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 73 | 74 | $17,185 | $8,469 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 79 | $10,075 | $4,292 | 42.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $4,780 | $3,083 | 64.5% |
| 92250 | Photography of the retina | Office | 2022 | 65 | 67 | $7,035 | $1,753 | 24.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 33 | 35 | $3,360 | $1,684 | 50.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 118 | $18,200 | $10,331 | 56.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 73 | $16,435 | $8,740 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 102 | $13,025 | $5,796 | 44.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $2,890 | $1,922 | 66.5% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 26 | 29 | $2,760 | $1,242 | 45.0% |
| 92250 | Photography of the retina | Office | 2021 | 38 | 39 | $4,095 | $1,156 | 28.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 89 | 95 | $18,525 | $10,024 | 54.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 91 | $13,689 | $6,658 | 48.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 63 | 115 | $14,250 | $5,267 | 37.0% |
| 92250 | Photography of the retina | Office | 2020 | 41 | 42 | $4,410 | $1,443 | 32.7% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 29 | 32 | $3,045 | $1,268 | 41.7% |
About Dr. James Levinson, O.D
Dr. James Levinson, O.D is a Optometrist healthcare provider based in Dolton, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376501767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Levinson, O.D has received a total of $1,280 in payments from pharmaceutical and medical device companies, with $20.62 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,262).
As a Medicare-enrolled provider, Levinson has provided services to 1,254 Medicare beneficiaries, totaling 1,645 services with total Medicare billing of $122,426. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Dolton, IL
- Active Since 05/03/2006
- Last Updated 02/11/2010
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1376501767
Products in Payments
- XIIDRA (Drug) $500.05
- VYZULTA (Drug) $293.15
- BIOTRUE (Device) $73.59
- BESIVANCE (Drug) $45.79
- OCULUS Keratograph 5M (Device) $44.01
- MIEBO (Drug) $38.46
- RESTASIS (Drug) $32.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.